Professor Angelika Amon, an award-winning cell biologist and “an advocate for the kinds of studies that grind away outside of the limelight,” died on Oct. 29, reports Bryan Marquard for The Boston Globe. Amon’s daughter, Clara Weis, noted that Amon “was pretty much the best role model there is. She was very caring and understanding. She always knew what was happening and how to deal with it the right way.”
Times Higher Ed reporter Matthew Reisz memorializes the life and work of Prof. Angelika Amon, a “trailblazing” scientist known for her research into the life cycle of cells. “Angelika existed in a league of her own,” says Whitehead fellow Kristin Knouse. “She had the energy and excitement of someone who picked up a pipette for the first time, but the brilliance and wisdom of someone who had been doing it for decades.”
The Association for the Advancement of Artificial Intelligence has awarded Prof. Regina Barzilay a $1 million prize for her work advancing the use of AI in medicine, reports John McCormick for The Wall Street Journal. "Regina is brilliant, has very high standards, and is committed to helping others,” says Prof. James Collins. “And I think her experience with—her personal experience with cancer—has motivated her to apply her intellectual talents to using AI to advance health care.”
The AP highlights how Prof. Regina Barzilay has been named the inaugural winner of a new award given by the Association for the Advancement of Artificial Intelligence for her work “using computer science to detect cancer and discover new drugs has won a new $1 million award for artificial intelligence.”
Prof. Regina Barzilay has been named the inaugural recipient of the Squirrel AI Award for Artificial Intelligence to Benefit Humanity for her work developing new AI techniques to help improve health care, reports Rebecca Robbins for STAT. Robbins writes that Barzilay is focused on turning the “abundance of research on AI in health care into tools that can improve care.”
MIT researchers have created a new synthetic lining that could be used to help treat digestive diseases, reports Pratibha Gopalakrishna for STAT. “We wanted to develop a liquid system that is easier to take compared to tablets or capsules, but had enhanced capabilities,” explains Prof. Giovanni Traverso.
New Scientist reporter Alice Klein writes that MIT researchers have developed a synthetic glue that could be used to line the small intestine and help treat several conditions, including diabetes and lactose intolerance. “The researchers found they could control the uptake of different nutrients,” writes Klein, “by adding various substances to the synthetic lining.”
MIT researchers outfitted a Boston Dynamics robotic dog with contactless vital sign monitoring equipment to help clinicians care for patients with Covid-19 without risking exposure, reports Darrell Etherington for TechCrunch. Etherington writes that the system “has the potential to not only reduce the risk of exposure for medical personnel, but also drastically reduce use of personal protective equipment.”
Reporting for CNN, Scottie Andrew highlights how researchers from MIT and Brigham and Women’s Hospital developed the iMASC, a silicon mask that can be reused and sterilized multiple times. Andrew notes that the mask is “a promising step toward addressing the critical healthcare supply shortages.”
Prof. Sangeeta Bhatia and senior postdoctoral associate Leslie Chan discuss their work developing a synthetic biosensor to diagnose lung disease. Chan explains that “instead of relying on naturally occurring breath volatiles, we wanted to be able to engineer the breath signal that we could use to monitor lung disease.”
CNBC reporter Cory Stieg writes about how researchers from MIT and Brigham and Women’s Hospital created a new reusable silicon mask with slots for small disposable N95 filters. “The masks themselves can be quickly and easily sterilized and reused, and though the small filters must be thrown out, each mask requires much less N95 material,” writes Stieg.
Fast Company reporter Adele Peters writes that researchers from MIT and Brigham and Women’s Hospital have developed a new face mask that is made of silicon and designed to be reused and sterilized repeatedly. “We wanted to have a system that could be accessible and used by anyone globally,” says Prof. Giovanni Traverso
Prof. Giovanni Traverso speaks with CBS Boston about a new silicon mask with N95 filters that can be reused and sterilized. “We recognize that not everybody has the sophisticated sterilization equipment but we also recognize that many folks around the world would have access to some kind of an oven or perhaps a solution of chlorine,” says Traverso.
UPI reporter Sommer Brokaw writes that researchers from MIT and Brigham and Women’s Hospital have created a new reusable silicon face mask with N95 filters. “The new masks have space for one or two N95 filters to be replaced after each use, and the rest of the rubber mask itself can be sterilized and reused many times,” writes Brokaw.
Researchers from MIT and Brigham and Women’s Hospital have designed a new reusable face mask outfitted with N95 filters that can be sterilized, reports WHDH.